MEK/ERK and PI3K/AKT pathways are often concurrently activated by separate genetic alterations in cancer cells but it was reported that ERK and AKT signaling cooperate to translationally regulate metastatic progression of certain types of cancer, e.g., colorectal cancer (Ye et al., 2013). This evidence concerns the gene MAP2K7 and cancer.